(NMRK) Newmark - Overview
Sector: Real Estate | Industry: Real Estate Services | Exchange: NASDAQ (USA) | Market Cap: 3.638m USD | Total Return: 32.9% in 12m
Avg Turnover: 21.7M
EPS Trend: 98.0%
Qual. Beats: 1
Rev. Trend: 98.0%
Qual. Beats: 6
Warnings
Share dilution 45.2% YoY
Below Avwap Earnings
Tailwinds
No distinct edge detected
Newmark Group, Inc. (NMRK) is a global commercial real estate services firm providing capital markets, leasing, and property management solutions. The company operates across major international markets, offering specialized debt and equity placement, investment sales, and loan servicing for diverse asset classes including multifamily and industrial properties.
The firm utilizes a diversified revenue model that balances transaction-based fees from brokerage with recurring income from property management and loan servicing. Within the commercial real estate sector, firms like Newmark often benefit from the increasing outsourcing of facilities management and corporate real estate strategy by multi-national corporations.
Newmark’s portfolio includes high-margin advisory services such as supply chain optimization and workplace strategy for global occupiers. Reviewing the latest technical indicators and valuation metrics on ValueRay can help clarify how these service lines impact current share pricing. The company remains a subsidiary of Cantor Fitzgerald, L.P., maintaining deep ties to institutional finance and capital markets.
- Interest rate stabilization accelerates transaction volume in commercial capital markets
- Higher debt placement activity increases mortgage brokerage and structured finance fees
- Expansion of multifamily loan servicing portfolio strengthens recurring high-margin revenue
- Corporate office downsizing trends reduce long-term tenant representation and leasing commissions
- Strategic talent acquisition costs impact operating margins during competitive hiring cycles
| Net Income: 149.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 4.65 > 1.0 |
| NWC/Revenue: 22.74% < 20% (prev 0.81%; Δ 21.93% < -1%) |
| CFO/TA 0.02 > 3% & CFO 103.8m > Net Income 149.4m |
| Net Debt (2.53b) to EBITDA (459.8m): 5.51 < 3 |
| Current Ratio: 1.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (256.0m) vs 12m ago 45.19% < -2% |
| Gross Margin: 94.78% > 18% (prev 1.00%; Δ 9.38k% > 0.5%) |
| Asset Turnover: 68.64% > 50% (prev 58.94%; Δ 9.70% > 0%) |
| Interest Coverage Ratio: 4.23 > 6 (EBITDA TTM 459.8m / Interest Expense TTM 65.9m) |
| A: 0.15 (Total Current Assets 1.92b - Total Current Liabilities 1.12b) / Total Assets 5.28b |
| B: 0.25 (Retained Earnings 1.32b / Total Assets 5.28b) |
| C: 0.06 (EBIT TTM 278.6m / Avg Total Assets 5.06b) |
| D: 0.37 (Book Value of Equity 1.32b / Total Liabilities 3.59b) |
| Altman-Z'' = 2.55 = A |
| DSRI: 2.27 (Receivables 1.58b/573.2m, Revenue 3.48b/2.86b) |
| GMI: 1.06 (GM 94.78% / 100.1%) |
| AQI: 1.07 (AQ_t 0.53 / AQ_t-1 0.49) |
| SGI: 1.22 (Revenue 3.48b / 2.86b) |
| TATA: 0.01 (NI 149.4m - CFO 103.8m) / TA 5.28b) |
| Beneish M = -1.72 (Cap -4..+1) = CCC |
As of May 29, 2026, the stock is trading at USD 14.26 with a total of 1,087,266 shares traded.
Over the past week, the price has changed by -1.38%,
over one month by -12.77%,
over three months by -1.20% and
over the past year by +32.93%.
Newmark has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy NMRK.
- StrongBuy: 1
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 19.6 | 37.3% |
P/E Trailing = 18.0247
P/E Forward = 5.7405
P/S = 1.047
P/B = 1.8528
Revenue TTM = 3.48b USD
EBIT TTM = 278.6m USD
EBITDA TTM = 459.8m USD
Long Term Debt = 832.0m USD (from longTermDebt, last quarter)
Short Term Debt = 1.12b USD (from shortTermDebt, last quarter)
Debt = 2.87b USD (from shortLongTermDebtTotal, last quarter) + Leases 505.1m
Net Debt = 2.53b USD (calculated: Debt 2.87b - CCE 335.0m)
Enterprise Value = 6.17b USD (3.64b + Debt 2.87b - CCE 335.0m)
Interest Coverage Ratio = 4.23 (Ebit TTM 278.6m / Interest Expense TTM 65.9m)
EV/FCF = 75.62x (Enterprise Value 6.17b / FCF TTM 81.6m)
FCF Yield = 1.32% (FCF TTM 81.6m / Enterprise Value 6.17b)
FCF Margin = 2.35% (FCF TTM 81.6m / Revenue TTM 3.48b)
Net Margin = 4.30% (Net Income TTM 149.4m / Revenue TTM 3.48b)
Gross Margin = 94.78% ((Revenue TTM 3.48b - Cost of Revenue TTM 181.3m) / Revenue TTM)
Gross Margin QoQ = 94.54% (prev none%)
Tobins Q-Ratio = 1.17 (Enterprise Value 6.17b / Total Assets 5.28b)
Interest Expense / Debt = 2.30% (Interest Expense 65.9m / Debt 2.87b)
Taxrate = 17.12% (3.43m / 20.0m)
NOPAT = 230.9m (EBIT 278.6m * (1 - 17.12%))
Current Ratio = 1.70 (Total Current Assets 1.92b / Total Current Liabilities 1.12b)
Debt / Equity = 1.70 (Debt 2.87b / totalStockholderEquity, last quarter 1.69b)
Debt / EBITDA = 5.51 (Net Debt 2.53b / EBITDA 459.8m)
Debt / FCF = 31.04 (Net Debt 2.53b / FCF TTM 81.6m)
Total Stockholder Equity = 1.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.95% (Net Income 149.4m / Total Assets 5.28b)
RoE = 9.81% (Net Income TTM 149.4m / Total Stockholder Equity 1.52b)
RoCE = 11.83% (EBIT 278.6m / Capital Employed (Equity 1.52b + L.T.Debt 832.0m))
RoIC = 4.67% (NOPAT 230.9m / Invested Capital 4.94b)
WACC = 6.88% (E(3.64b)/V(6.51b) * Re(10.81%) + D(2.87b)/V(6.51b) * Rd(2.30%) * (1-Tc(0.17)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 42.22 | Cagr: 18.96%
[DCF] Terminal Value 75.44% ; FCFF base≈81.6m ; Y1≈82.0m ; Y5≈86.8m
[DCF] Fair Price = N/A (negative equity: EV 1.35b - Net Debt 2.53b = -1.18b; debt exceeds intrinsic value)
EPS Correlation: 97.96 | EPS CAGR: 24.31% | SUE: 3.67 | # QB: 1
Revenue Correlation: 98.05 | Revenue CAGR: 15.50% | SUE: 2.82 | # QB: 6
EPS current Quarter (2026-06-30): EPS=0.38 | Chg30d=-6.10% | Revisions=-50% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.49 | Chg30d=+1.44% | Revisions=+33% | Analysts=6
EPS current Year (2026-12-31): EPS=1.93 | Chg30d=+2.60% | Revisions=+60% | GrowthEPS=+19.4% | GrowthRev=+15.4%
EPS next Year (2027-12-31): EPS=2.16 | Chg30d=+2.12% | Revisions=+60% | GrowthEPS=+11.9% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +60%